We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
- Authors
Prados, Michael D; Chang, Susan M; Butowski, Nicholas; DeBoer, Rebecca; Parvataneni, Rupa; Carliner, Hannah; Kabuubi, Paul; Ayers-Ringler, Jennifer; Rabbitt, Jane; Page, Margaretta; Fedoroff, Anne; Sneed, Penny K; Berger, Mitchel S; McDermott, Michael W; Parsa, Andrew T; Vandenberg, Scott; James, C David; Lamborn, Kathleen R; Stokoe, David; Haas-Kogan, Daphne A
- Abstract
This open-label, prospective, single-arm, phase II study combined erlotinib with radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and gliosarcoma. The objectives were to determine efficacy of this treatment as measured by survival and to explore the relationship between molecular markers and treatment response.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 4, p579
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2008.18.9639